StockDuty ← Dashboard Sep 18, 2026 04:58 AM ET
CatalystFDA/Bio

Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-M

Phase 3 pediatric EMPAVELI data show proteinuria reduction and stabilized kidney function in adolescents.

Phase 3 pediatric EMPAVELI data show proteinuria reduction and stabilized kidney function in adolescents.
Phase 3 pediatric EMPAVELI data show proteinuria reduction and stabilized kidney function in adolescents. — impact context not separately stored; see What changed.
Sources